BR9405997A - Composições antitumorais e métodos de tratamento - Google Patents

Composições antitumorais e métodos de tratamento

Info

Publication number: BR9405997A
Authority: BR; Brazil
Prior art keywords: treatment methods; indolinesulfonamide; indolesulfonamide; chem; derivatives
Prior art date: 1993-03-10

Application number

BR9405997A

Other languages

English (en)

Inventor

Gerald Burr Grindey

Cora Sue Grossman

James Jeffrey Howbert

James Edward Ray

John Eldon Toth

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-03-10

Filing date

1994-03-10

Publication date

1995-12-19

1994-03-10 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1995-12-19 Publication of BR9405997A publication Critical patent/BR9405997A/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)

BR9405997A 1993-03-10 1994-03-10 Composições antitumorais e métodos de tratamento BR9405997A (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US2909593A	1993-03-10	1993-03-10
PCT/US1994/002606 WO1994020101A1 (en)	1993-03-10	1994-03-10	Antitumor compositions and methods of treatment

Publications (1)

Publication Number	Publication Date
BR9405997A true BR9405997A (pt)	1995-12-19

Family

ID=21847185

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9405997A BR9405997A (pt)	1993-03-10	1994-03-10	Composições antitumorais e métodos de tratamento

Country Status (20)

Country	Link
EP (1)	EP0614887B1 (pt)
JP (1)	JPH08507532A (pt)
KR (1)	KR960700710A (pt)
AT (1)	ATE154345T1 (pt)
AU (1)	AU687042B2 (pt)
BR (1)	BR9405997A (pt)
CA (1)	CA2157801A1 (pt)
CZ (1)	CZ232695A3 (pt)
DE (1)	DE69403695T2 (pt)
DK (1)	DK0614887T3 (pt)
ES (1)	ES2102774T3 (pt)
FI (1)	FI954213L (pt)
GR (1)	GR3023827T3 (pt)
HU (1)	HU218660B (pt)
NO (1)	NO953557L (pt)
NZ (1)	NZ263080A (pt)
PL (1)	PL310558A1 (pt)
RU (1)	RU2127259C1 (pt)
WO (1)	WO1994020101A1 (pt)
ZA (1)	ZA941500B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU709107B2 (en) *	1996-08-22	1999-08-19	Dong Wha Pharmaceutical Industrial Co., Ltd.	Arylsulfonylimidazolone derivatives as an antitumor agent
JP2000247949A (ja) *	1999-02-26	2000-09-12	Eisai Co Ltd	スルホンアミド含有インドール化合物
DE19919793A1 (de)	1999-04-30	2000-11-02	Bayer Ag	Neue Sulfonamide
ATE375978T1 (de)	2002-11-22	2007-11-15	Lilly Co Eli	Benzoylsulfonamide als antitumor-mittel
TWI315304B (en) *	2006-08-31	2009-10-01	Univ Taipei Medical	Indoline-sulfonamides compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1240866B (de) *	1961-06-29	1967-05-24	Heyden Chem Fab	Verfahren zur Herstellung von Indolin-6-sulfonylharnstoffen
US5116874A (en) *	1985-09-23	1992-05-26	Eli Lilly And Company	Anti-tumor method and compounds
GR862353B (en) *	1985-09-23	1987-01-19	Lilly Co Eli	Anti-tumor method and compounds
CA1331464C (en) *	1987-05-12	1994-08-16	Eli Lilly And Company	Anti-tumor method and compounds
ZA915371B (en) *	1990-07-17	1993-03-31	Lilly Co Eli	Antitumor compositions and methods of treatment
US5169860A (en) *	1992-03-13	1992-12-08	Eli Lilly And Company	Antitumor compositions and methods of treatment

1994
- 1994-03-03 ZA ZA941500A patent/ZA941500B/xx unknown
- 1994-03-09 ES ES94301671T patent/ES2102774T3/es not_active Expired - Lifetime
- 1994-03-09 DE DE69403695T patent/DE69403695T2/de not_active Expired - Fee Related
- 1994-03-09 EP EP94301671A patent/EP0614887B1/en not_active Expired - Lifetime
- 1994-03-09 AT AT94301671T patent/ATE154345T1/de not_active IP Right Cessation
- 1994-03-09 DK DK94301671.7T patent/DK0614887T3/da active
- 1994-03-10 RU RU95122639A patent/RU2127259C1/ru active
- 1994-03-10 KR KR1019950703798A patent/KR960700710A/ko not_active Ceased
- 1994-03-10 PL PL94310558A patent/PL310558A1/xx unknown
- 1994-03-10 HU HU9502627A patent/HU218660B/hu not_active IP Right Cessation
- 1994-03-10 FI FI954213A patent/FI954213L/fi unknown
- 1994-03-10 NZ NZ263080A patent/NZ263080A/en unknown
- 1994-03-10 JP JP6520310A patent/JPH08507532A/ja active Pending
- 1994-03-10 AU AU63638/94A patent/AU687042B2/en not_active Ceased
- 1994-03-10 WO PCT/US1994/002606 patent/WO1994020101A1/en not_active Ceased
- 1994-03-10 CZ CZ952326A patent/CZ232695A3/cs unknown
- 1994-03-10 CA CA002157801A patent/CA2157801A1/en not_active Abandoned
- 1994-03-10 BR BR9405997A patent/BR9405997A/pt not_active Application Discontinuation
1995
- 1995-09-08 NO NO953557A patent/NO953557L/no unknown
1997
- 1997-06-19 GR GR970401465T patent/GR3023827T3/el unknown

Also Published As

Publication number	Publication date
JPH08507532A (ja)	1996-08-13
CA2157801A1 (en)	1994-09-15
EP0614887B1 (en)	1997-06-11
PL310558A1 (en)	1995-12-27
FI954213A0 (fi)	1995-09-08
KR960700710A (ko)	1996-02-24
ZA941500B (en)	1995-09-04
NO953557D0 (no)	1995-09-08
EP0614887A1 (en)	1994-09-14
DK0614887T3 (da)	1997-10-20
HU9502627D0 (en)	1995-11-28
HU218660B (hu)	2000-10-28
DE69403695D1 (de)	1997-07-17
HUT72897A (en)	1996-06-28
DE69403695T2 (de)	1997-10-30
NO953557L (no)	1995-11-02
WO1994020101A1 (en)	1994-09-15
RU2127259C1 (ru)	1999-03-10
FI954213A7 (fi)	1995-10-11
NZ263080A (en)	1996-12-20
ES2102774T3 (es)	1997-08-01
AU687042B2 (en)	1998-02-19
GR3023827T3 (en)	1997-09-30
ATE154345T1 (de)	1997-06-15
FI954213L (fi)	1995-10-11
AU6363894A (en)	1994-09-26
CZ232695A3 (en)	1996-01-17

Publication	Publication Date	Title
GR3036455T3 (en)	2001-11-30	Atherosclerosis treatment
HUT66660A (en)	1994-12-28	Intermediates for producing 9-[(substituted glicyl)-amido]-6-demetyl-6-deoxy-tetracyclines and pharmaceutical compositions containing them
SG47520A1 (en)	1998-04-17	New method for the production of 9-amino-6-demethyl-6-deoxytetracycline
ATE343367T1 (de)	2006-11-15	Photostabile organische sonnenschutzmittel mit antioxidativen eigenschaften und zusammensetzungen damit
IL110151A0 (en)	1994-10-07	Amide and urea derivatives and pharmaceutical compositions containing the same
TW280813B (pt)	1996-07-11
BR9405997A (pt)	1995-12-19	Composições antitumorais e métodos de tratamento
IL102409A0 (en)	1993-01-14	Mono and bis alkylamino-anthracyclines,their preparation and pharmaceutical compositions containing them
GR3023757T3 (en)	1997-09-30	Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents.
HUT70761A (en)	1995-10-30	Alkyl derivatives of trazodone having action for central nervous system, pharmaceutical compositions for preparing thereof
DE3483735D1 (en)	1991-01-24	Hexahydropyrrolo(2,1-a)isochinolinderivate.
ZA924888B (en)	1993-04-28	Process for the synthesis of enantiomers of 3-aminochroman compounds
TW275629B (pt)	1996-05-11
DE3781986D1 (de)	1992-11-05	Substituierte chinoxaline.
EP0443474A3 (en)	1992-04-22	1-phenoxycarbonyl-2-pyrrolidinone derivatives and nootropic agents

Legal Events

Date	Code	Title	Description
1999-06-08	EG	Technical examination (opinion): publication of technical examination (opinion)
2000-02-01	FC	Decision: refusal